Current issue #33, 2015

Washout without response 

Drug manufacturing in lowest price segment keeps falling

Top managers of the local drug manufacturing facilities raise alarm as it becomes increasingly unfeasible to produce the cheapest drugs on the VED list, which results in the reduction of their output. In this regard, a number of local enterprises united and wrote a few applications to the Federation Council and a variety of ministries. Two of these applications were addressed personally to Federation Council Chairwoman Valentina Matvienko and Minister of Industry and Trade Denis Manturov. More than 6 months passed since these applications have been sent; meanwhile, in the applicants’ opinion, the situation has been growing only worse. The Ministry of Industry and Trade informed PharmVestnik that “no complete termination of drug manufacturing has been recorded for any INN” and that the ministry has anyway done a lot for the low-cost drug manufacturers. The Ministry of Health and Federal Antimonopoly Services have refused to comment. 

[PharmVestnik # 33, 20/10/2015, p. 1, cont’d p.2]

Time to get worried 

Vaccine manufacturers puzzled over creation of state monopoly 

The creation of a state monopoly in the vaccine market has stirred up the pharmaceutical community as this event has specifically defined the state involvement vector in this segment. However, the participants of the 7^th International Conference “What is Going On in the Pharmaceutical Market?” stated that as of now they did not understand the vaccine purchase and supply structure. PharmVestnik received a response from Natsimbio, the single vaccine supplier whose “birth” has set the rest of the market players on fire. This single supplier has clearly specified its stand: there is going to be room in the market only for those ready to implement a full-cycle manufacturing of their own. 

[PharmVestnik # 33, 20/10/2015, p. 1, cont’d p. 3]

Failing to keep their noses to the wind

Russian and foreign experts disagree on Pharma industry development paths

The panel meeting on the government policy of the pharmaceutical industry and medical devices development held on October 12 at the Chamber of Industry and Commerce of the Russian Federation was significantly livened up by the presentation of a “guest star” from Maastricht University. Before Prof. Meir Pugatch started demo...